Trending

inflammatory bowel disease

J&J gets Stelara okay in Europe for ulcerative colitis

J&J gets Stelara okay in Europe for ulcerative colitis

Johnson & Johnson’s inflammatory disease drug Stelara has been approved in Europe for ulcerative colitis (UC), a new

X

J&J gets Stelara okay in Europe for ulcerative colitis

https://pharmaphorum.com/news/jj-gets-stelara-okay-in-europe-for-ulcerative-colitis/

Allergan says it will shed two drugs as AbbVie takeover looms

Allergan says it will shed two drugs as AbbVie takeover looms

Allergan has confirmed that it will divest experimental inflammatory bowel disease therapy brazikumab and marketed drug Zenpep ahead

X

Allergan says it will shed two drugs as AbbVie takeover looms

https://pharmaphorum.com/news/allergan-says-it-will-shed-two-drugs-as-abbvie-takeover-looms/

FDA approves oral treatment for ulcerative colitis

FDA approves oral treatment for ulcerative colitis

Pfizer’s janus kinase (JAK) inhibitor drug Xeljanz (tofacitinib) has received expanded approval from the FDA for adults with moderately-to-severely-active ulcerative colitis.

X

FDA approves oral treatment for ulcerative colitis

https://pharmaphorum.com/news/fda-oral-treatment-ulcerative-colitis/

Gilead to collaborate with Google’s Verily in inflammatory diseases

Gilead to collaborate with Google’s Verily in inflammatory diseases

Gilead has signed a three-year deal with Google’s life science division Verily to work on identifying the immunological

X

Gilead to collaborate with Google’s Verily in inflammatory diseases

https://pharmaphorum.com/news/gilead-google-verily-inflammatory-disease-research/

Janssen inks potential $1bn deal for IBD drug

Janssen has swooped to buy rights to an early-stage oral inflammatory bowel disease drug from Protagonist Therapeutics in

X

Janssen inks potential $1bn deal for IBD drug

https://pharmaphorum.com/news/janssen-inks-potential-1bn-deal-ibd-drug/

Takeda teams up with Marvel in IBD campaign

Takeda teams up with Marvel in IBD campaign

IBD super hero is at centre of awareness campaign.

X

Takeda teams up with Marvel in IBD campaign

https://pharmaphorum.com/news/takeda-teams-marvel-ibd-campaign/

Shire buys rights to Pfizer gastrointestinal drug

Shire buys rights to Pfizer gastrointestinal drug

Shire has bought rights to PF-00547659 for an undisclosed sum.

X

Shire buys rights to Pfizer gastrointestinal drug

https://pharmaphorum.com/news/pfizer-buys-rights-pfizer-gastrointestinal-drug/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com